Launched on 6th of October 2026

Cardio.toolsby Mohamed Ghazy, MD CardiologyAin Shams University, Egypt · Cardiology Consultant, Saudi ArabiaScopus ID: 55257919100
Interventions

DAPT Score

For patients who completed 12 months of DAPT without major bleeding or ischaemic events. Balances ischaemic benefit against bleeding risk of continuing thienopyridine.

Upload a report, lab sheet or echo picture to fill this calculator automatically.
Age
Additional criteria
Tap every item that applies
Total score
0
Low benefit
Prolonged DAPT: ↑ bleeding (NNH ≈ 64) without meaningful ischaemic reduction.
Decision guide
Stop P2Y12 inhibitor at 12 months; continue single antiplatelet therapy.
1 section is still unanswered — counted as 0 points.
Ranges: -2–1 Low benefit2–10 Favourable benefit/risk
References
  1. Yeh RW, et al. Development and validation of a prediction rule for benefit and harm of DAPT beyond 1 year after PCI. JAMA 2016;315:1735-1749.
  2. Levine GN, et al. 2016 ACC/AHA Guideline Focused Update on Duration of DAPT. J Am Coll Cardiol 2016;68:1082-1115.
More in Interventions